Logo

American Heart Association

  34
  0


Final ID: 4367847

Predictors of Mechanical Circulatory Support Utilization Across Racial and Ethnic Groups in Heart Failure–Related Cardiogenic Shock: A National Perspective

Abstract Body (Do not enter title and authors here): Background: Mechanical circulatory support (MCS) is pivotal in treating heart-failure–related cardiogenic shock (HF-CS), yet real-world deployment may hinge on social and institutional forces in addition to clinical need. We quantified predictors of MCS use across racial and ethnic groups.
Methods: The National Inpatient Sample (2016–2020) identified 120,190 adult HF-CS hospitalizations. MCS therapies included intra-aortic balloon pump, percutaneous ventricular assist devices, extracorporeal membrane oxygenation, and heart transplantation. Multivariable logistic regression generated adjusted odds ratios (aORs) for MCS use.
Results: Of all admissions, 60.5 % were White, 25.3 % Black, 7.8 % Hispanic, and 6.4 % Other. MCS was employed in 15.4% of White, 15.2% of Black, 15.1% of Hispanic, and 20.1% of Other patients. Female sex conferred 22–35 % lower odds of receiving MCS (aOR 0.73 in Whites, 0.78 in Hispanics, and 0.65 in Black women; p < 0.01). Patients older than 60 years were likewise less likely to receive support in Hispanics, whites, and blacks (aOR 0.62, 0.68 & 0.75; all p< 0.05). Possessing private insurance increased the likelihood of MCS by 59 % to 151 % (aOR 1.52–2.51, p< 0.05 for all except Asians). Higher income was associated with greater MCS use only among Hispanic patients (aOR 1.27, p = 0.001). Admission to a large-bed-size hospital was the strongest institutional determinant, doubling the odds of support for all groups and up to fourfold in the Others (aOR 4.25, p< 0.001). Medicare/Medicaid coverage showed no significant association with utilisation. Clinically, chronic obstructive pulmonary disease markedly reduced the likelihood of MCS (aOR 0.10–0.65, p ≤ 0.009). Stage-5 chronic kidney disease and atrial fibrillation conferred modestly lower odds only in Whites (aOR 0.75 and 0.80, respectively; p ≤ 0.005) and in patients classified as Other (aOR 0.60 for atrial fibrillation, p = 0.006).
Conclusion: Access to temporary MCS in HF-CS extends beyond clinical eligibility. Women and older adults are less likely to receive support, whereas private insurance, higher income (for Hispanics), and care in large hospitals substantially increase utilisation. Racial and ethnic disparities intersect with socioeconomic status and institutional resources., Black and Hispanic patients—particularly Black women—remain underrepresented among MCS recipients. These findings highlight structural determinants in advanced HF care and underscore the need for targeted.
  • Goyal, Samarth  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Alhuneafat, Laith  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Ghanem, Fares  ( southern illinois university , Springfield , Illinois , United States )
  • Naser, Abdullah  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Jain, Shubhika  ( Louisiana state university health , Shreveport , Louisiana , United States )
  • Bilal, Muhammad Ibraiz  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Obeidat, Omar  ( UCF HCA North Florida , Gainesville , Florida , United States )
  • Abdallah, Ala  ( Kirk Kerkorian School of Medicine , Las Vegas , Nevada , United States )
  • Maaita, Ahmad  ( Jordan university , Amman , Jordan )
  • Jabri, Ahmad  ( Beaumont Royal Oak University , Michigan , Michigan , United States )
  • Author Disclosures:
    Samarth Goyal: DO NOT have relevant financial relationships | Laith Alhuneafat: DO NOT have relevant financial relationships | Fares Ghanem: No Answer | Abdullah Naser: DO NOT have relevant financial relationships | Shubhika Jain: DO NOT have relevant financial relationships | Muhammad Ibraiz Bilal: DO NOT have relevant financial relationships | Omar Obeidat: DO NOT have relevant financial relationships | Ala Abdallah: DO NOT have relevant financial relationships | Ahmad Maaita: DO NOT have relevant financial relationships | Ahmad Jabri: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Dickinson W. Richards Memorial Lecture

Monday, 11/10/2025 , 09:45AM - 11:00AM

Abstract Oral Session

More abstracts on this topic:
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes – The DANLOGIC-HF Preliminary Registry Findings

Witten Davodian Lise, Chien Christopher, Fudim Marat, Hernandez Adrian, Kwan Brian, Stolen Craig, Biering-soerensen Tor, Dyrby Johansen Niklas, Sattler Stefan Michael, Wolsk Emil, Risum Niels, Kober Lars, Gustafsson Finn, Davodian Danny, Solomon Scott

Association between small pre-implant left ventricular end diastolic diameter and post left ventricular assist device implantation all-cause mortality: A systematic review and meta-analysis

Pingili Adhvithi, Feller Erika, Vadiyala Mounika Reddy, Anmol Kumar, Jain Muskan, Varghese Jeffy Susan, Ahluwalia Vibhor, Prajapati Kesar, Chalasani Vardhan, Desai Rupak

More abstracts from these authors:
Use of Contemporary Cardiometabolic Therapies in Cardiac Amyloidosis Treated with Tafamidis: A Real-World Propensity-Matched Analysis

Obeidat Omar, Alhuneafat Laith, Goyal Samarth, Abdallah Ala, Maharaj Valmiki

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Mortality and Cardiovascular Outcomes Following TAVR in Heart Failure Patients: A Propensity-Matched Cohort Study

Obeidat Omar, Villablanca Pedro, Alhuneafat Laith, Alayyat Ahmad, Naser Abdallah, Ghanem Fares, Jabri Ahmad, Brankovic Milos, Jiao Tianze, Ruzieh Mohammed, Alexy Tamas

You have to be authorized to contact abstract author. Please, Login
Not Available